Key Highlights
- Amesite (AMST) shares skyrocketed 190% during Tuesday’s premarket session following news of a major enterprise agreement.
- The company’s biggest client to date will implement NurseMagic AI documentation tools for staff supporting roughly 2,700 patients.
- NurseMagic will be integrated directly with the client’s electronic medical records (EMR) and electronic visit verification (EVV) infrastructure.
- The system aims to slash documentation hours by as much as 16 hours weekly for each care provider.
- The company has trimmed operational expenses by approximately 18% across the previous six quarters.
On May 18, 2026, Amesite Inc. revealed it had signed its most significant home care enterprise client for the NurseMagic AI documentation solution. The announcement triggered a 190% surge in AMST shares during premarket hours Tuesday.
This new enterprise partner provides services to roughly 2,700 patients and plans to deploy NurseMagic throughout its entire caregiver workforce. The AI platform will connect seamlessly with existing electronic medical record infrastructure and electronic visit verification tools.
The primary value proposition centers on dramatic time savings. Currently, caregivers spend up to 16 hours weekly on documentation tasks, and NurseMagic promises to significantly reduce that administrative load.
Founder and CEO Dr. Ann Marie Sastry emphasized the significance: “This deployment covering 2,700 patients demonstrates the robustness of our platform architecture.” She highlighted that Amesite can onboard new enterprise clients rapidly, avoiding the expensive consulting fees and custom development requirements that plague traditional legacy solutions.
The implementation handles diverse user roles, hierarchical permission structures, and customized documentation workflows for thousands of patients — all without the prolonged setup process that can drag on for weeks or months with established systems.
Financial Discipline Accompanies Revenue Expansion
Amesite’s major contract announcement arrives amid ongoing cost optimization efforts. Sarah Berman, Principal Finance and Accounting Officer, highlighted roughly 18% in operational spending reductions over the past six quarters, achieved while simultaneously expanding the paying customer roster.
This combination of fiscal discipline and business growth is particularly noteworthy for micro-cap equities. With a current market capitalization hovering around $4.48 million, any substantial enterprise agreement carries significant financial weight for Amesite.
Madison Bush, Director of Corporate Operations, shared that marketing and sales initiatives are driving approximately 4,200 daily website visitors. She further indicated that more than 70% of qualified prospects currently in discussions have independently booked product demonstrations via the company website.
Growing Sales Pipeline Suggests Future Opportunities
Beyond this latest deployment, Amesite disclosed ongoing negotiations with multiple organizations that collectively represent several thousand additional patients. The company has not disclosed specific names or projected timelines for these potential agreements.
NurseMagic currently serves over 100 healthcare professions spanning all 50 states and 21 nations worldwide. The solution offers multilingual support and maintains full HIPAA compliance standards.
AMST typically trades approximately 682,000 shares daily on average. Technical indicators had previously rated the stock as a sell, though that assessment preceded Tuesday’s major announcement.
This 2,700-patient contract represents the company’s largest deployment to date and, per management commentary, signals NurseMagic’s evolution from a supplementary productivity tool into essential clinical infrastructure within the non-acute healthcare sector.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
